ArticleJournal of clinical and translational hepatology2026

Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China.

Jinlin Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.